2022
DOI: 10.1042/bsr20221002
|View full text |Cite
|
Sign up to set email alerts
|

FBP1 knockdown decreases ovarian cancer formation and cisplatin resistance through EZH2-mediated H3K27me3

Abstract: Worldwide, ovarian cancer (OC) is the seventh common cancer and the second most common cause of cancer death in women. Due to high rates of relapse, there is an urgent need for the identification of new targets for OC treatment. The far-upstream element binding protein 1 (FBP1) and enhancer of zeste homolog 2 (EZH2) are emerging proto-oncogenes that regulate cell proliferation and metastasis. In the present study, Oncomine data analysis demonstrated that FBP1 was closely associated with the development of OC, … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 66 publications
0
1
0
Order By: Relevance
“…7 The onset of ovarian cancer is insidious, with atypical initial symptoms, making detection by patients or diagnosis by doctors difficult. Over 50% of patients are diagnosed at advanced stages, 8 often miss the best time for intervention, 9,10 and the 3-year survival rate is lower than 30%. 11 The prevention and treatment of ovarian cancer have become major social and public health issues.…”
Section: Introductionmentioning
confidence: 99%
“…7 The onset of ovarian cancer is insidious, with atypical initial symptoms, making detection by patients or diagnosis by doctors difficult. Over 50% of patients are diagnosed at advanced stages, 8 often miss the best time for intervention, 9,10 and the 3-year survival rate is lower than 30%. 11 The prevention and treatment of ovarian cancer have become major social and public health issues.…”
Section: Introductionmentioning
confidence: 99%